tiprankstipranks
Trending News
More News >
Wuxi Biologics (Cayman) (HK:2269)
:2269
Hong Kong Market
Advertisement

Wuxi Biologics (Cayman) (2269) Financial Statements

Compare
51 Followers

Wuxi Biologics (Cayman) Financial Overview

Wuxi Biologics (Cayman)'s market cap is currently HK$159.64B. The company's EPS TTM is HK$0.6007482030000001; its P/E ratio is 35.04; Wuxi Biologics (Cayman) is scheduled to report earnings on August 19, 2025, and the estimated EPS forecast is HK$0.58. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in CNY

Wuxi Biologics (Cayman) Earnings and Revenue History

Wuxi Biologics (Cayman) Debt to Assets

Wuxi Biologics (Cayman) Cash Flow

Wuxi Biologics (Cayman) Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis